BUMETANIDE
- Product NDC
- 51662-1449
- 11-digit product format
- 516621449
- Labeler code
- 51662
- Product ID
- 51662-1449_2b395f11-a2e3-6a43-e063-6394a90a4efa
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- BUMETANIDE
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Application
- ANDA079196
- Marketing category
- ANDA
- Marketing start
- 2020-01-11
- Substance
- BUMETANIDE
- Active strength
- .25 mg/mL
- Pharmacologic classes
- Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- BUMETANIDE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BUMETANIDE | .25 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 0Y2S3XUQ5H |
| Rxcui | 1727569 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51662-1449-1 | BUMETANIDE | 4 mL in 1 VIAL | INJECTION | 4 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51662-1449 | BUMETANIDE INJECTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 3 | Current NDC, Legacy NDC, 1 package rows | 20250110_9bd7a71e-0e78-dae7-e053-2995a90ad110.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51662-1449-1 | 51662144901 | 4 mL in 1 VIAL (51662-1449-1) | 4 ml | 2020-01-11 | 0000-00-00 | No | No | Current |